Sanofi India Ltd.

Financial

	Sanofi India	Jubilant Pharmova	Caplin Point Lab
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	0.6 %	n/a	n/a
Unclassified
R&D as a % of Total Sales	0.0	0.33 %	4.4 %
Financials
5 yr Average ROE	52.02 %	8.35 %	20.61 %
5yr average Equity Multiplier	4.62	2.0	1.17
5yr Average Asset Turnover Ratio	0.47	0.59	0.72
5yr Avg Net Profit Margin	24.38 %	7.13 %	24.8 %
Price to Book	16.8	2.44	5.4
P/E	34.99	23.13	26.64
5yr Avg Cash Conversion Cycle	4.83 Days	-19.21 Days	79.85 Days
Inventory Days	66.8 Days	81.78 Days	64.55 Days
Days Receivable	31.98 Days	51.11 Days	100.92 Days
Days Payable	63.37 Days	173.51 Days	74.04 Days
5yr Average Interest Coverage Ratio	906.11	3.98	579.71
5yr Avg ROCE	27.19 %	9.05 %	25.27 %
5yr Avg Operating Profit Margin	24.71 %	18.69 %	30.87 %
5 yr average Debt to Equity	0.0	0.64	0.01
5yr CAGR Net Profit	31.63 %	-38.8 %	16.28 %
5yr Average Return on Assets	11.5 %	4.23 %	17.7 %
Shareholdings
Promoter Holding	60.4 %	50.68 %	70.56 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	1.67 %
Change in Mutual Fund Holding (3 Yrs)	1.07 %	3.61 %	0.55 %

Business

	Sanofi India	Jubilant Pharmova	Caplin Point Lab
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Branded Generic 0 Generic 0	Product Wise Break-Up Radiopharmaceuticals 44.9 India branded pharmaceuticals 0.72 Specialty intermediates 0 Nutritional products 0 Pharmaceutical 0 Contract Research and Development Services 6.7 Contract Manufacturing 16.81 Life science chemicals 0 Anti-allergic 10.21 Active Pharmaceutical Ingredient (API) 9.26 Generic 0 Solid dosage formulations 10.82 Branded Generic 0 Others 0.58	Product Wise Break-Up Radiopharmaceuticals 0 India Branded pharmaceuticals 0 Specialty intermediates 0 Nutritional products 0 Pharmaceutical 0 0 0 Life science chemicals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 Formulations 75.0 Solid dosage formulations 0 Branded Generics 25.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 38.81 Cardiac Science 17.42 Respiratory Systems 13.48 Gastro Intestinal 10.56 Pain Management 7.15 Central Nervous System (CNS) 6.86 Anti-Infective 5.72 DERMA 0 VMN 0	-	-
Location Wise Break-Up	Location Wise Break-Up India 81.47 Singapore 17.88 Rest of the World 0 China 0 Americas and Europe 0 USA 0 Africa 0 LATAM 0 Others 0.65	Location Wise Break-Up Americas and Europe 90.17 USA 0 China 0 Rest of the World 7.5 India 2.33 Singapore 0 LATAM 0 Africa 0	Location Wise Break-Up Americas and Europe 0 USA 18.0 China 0 Rest of the World 0 India 0 Singapore 0 Latin America 80.0 Africa 2.0

Sanofi India Ltd.

SIGN UP FOR FREE